Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 558541
                    [Title] => Novartis cuts price  of Clozapine by 35%
                    [Summary] => 
Novartis Healthcare Philippines has voluntarily reduced by 35 percent the current retail price of its anti-psychotic brand of Clozapine, Leponex.
                    [DatePublished] => 2010-03-18 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

LEPONEX

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 558541
                    [Title] => Novartis cuts price  of Clozapine by 35%
                    [Summary] => 
Novartis Healthcare Philippines has voluntarily reduced by 35 percent the current retail price of its anti-psychotic brand of Clozapine, Leponex.
                    [DatePublished] => 2010-03-18 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Novartis cuts price of Clozapine by 35%

March 18, 2010 - 12:00am

Novartis Healthcare Philippines has voluntarily reduced by 35 percent the current retail price of its anti-psychotic brand of Clozapine, Leponex.

Science and Environment